Apnimed is committed to revolutionizing the treatment of sleep-related breathing diseases - for a rested, vibrant, and healthy world.

Our company is advancing a focused product development program of novel oral pharmaceutical product candidates designed to treat OSA and other types of sleep-related breathing diseases. To accomplish this, we seek diverse perspectives and skills to drive us toward innovation and richer outcomes.

Current Openings